Context Therapeutics CNTX
NASDAQ CNTX
$0.17 +0.00 (+0.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Context Therapeutics (CNTX) Debt Ratio (2020)

Updated

Context Therapeutics' Debt Ratio was 12.74 in Q4 2020.

Analysis

Context Therapeutics (CNTX) Debt Ratio (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 0.60
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 0.33
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 0.23
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 0.55
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 0.41
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 0.56
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 0.51
9 Gsk 193.54 Bn 176.38 Bn - -0.33
10 Context Therapeutics 15.24 Mn -182.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 12.74
API Access

Context Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=CNTX&period=max&api_key=YOUR_API_KEY